Bioasia Mangement LLC insider trades: Soleno Therapeutics (SLNO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bioasia Mangement LLC reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2019 | SLNO | ↓ Sell | 90,724 | $1.93 | $175K | Indirect | May 21, 2019 (1d) |
| Jan 19, 2010 | BFRM | ↓ Sell | 420,054 | $5.51 | $2.3M | By Biotechnology Development Fund II, L. | Jan 21, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLNO insiders
Open-market trades in the last 12 months
About Bioasia Mangement LLC's insider trades
Bioasia Mangement LLC is a 10% owner of Soleno Therapeutics (SLNO). Since Jan 19, 2010, it has reported no open-market purchases and 2 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLNO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.